文献速递骨肌MR

对肱骨近端及膝关节周围孤立性中心性软骨肿瘤管理影像学方案的回溯性验证

A retrospective validation of an imaging protocol for the management of solitary central cartilage tumours of the proximal humerus and around the knee.
PubMed 文献 · Clin Radiol · 2019-10-03

回顾性纳入10年间387例肱骨近端、股骨远端和胫骨近端中心性软骨肿瘤患者,按BACTIP分为七型并评估恶性转化延误情况。恶性(软骨肉瘤)发生率随BACTIP分型升高而增加,仅1例因应用方案导致软骨肉瘤诊断延迟5个月。研究确认BACTIP是普通放射科医生初始评估中心性软骨肿瘤的有用工具,但近端腓骨除外。

要点

  • BACTIP分型IA和IB型100%为良性内生软骨瘤,IIA型96%良性,IIB型83%良性。
  • IIC型57%诊断为恶性,III型97%诊断为恶性。
  • 仅1例因应用方案导致软骨肉瘤诊断延迟5个月。

核心结论

  • 回溯性研究确认BACTIP是普通放射科医生初始评估肱骨近端及膝关节周围中心性软骨肿瘤的有用工具,近端腓骨除外,尤其有助于确定哪些病例需及时转诊至专科骨科肿瘤服务进一步评估。

研究设计与样本

  • 回顾性研究,10年间纳入387例肱骨近端、股骨远端和胫骨近端中心性软骨肿瘤患者,转诊至单一单位Royal Orthopaedic Hospital专科骨科肿瘤服务,评估初始MRI及随访图像的肿瘤长度、骨内膜扇贝样改变及侵袭性/恶性特征,按BACTIP分为七型。

诊断标准与关键数值

  • BACTIP分型IA和IB型良性(内生软骨瘤)诊断率100%。
  • BACTIP分型IIA型良性诊断率96%。
  • BACTIP分型IIB型良性诊断率83%。
  • BACTIP分型IIC型恶性诊断率57%。
  • BACTIP分型III型恶性诊断率97%。

临床应用与阅片要点

  • 作者认为BACTIP可作为普通放射科医生初始评估中心性软骨肿瘤的有用工具,近端腓骨除外。
  • 应用BACTIP有助于确定哪些病例需及时转诊至专科骨科肿瘤服务进一步评估,仅1例导致软骨肉瘤诊断延迟5个月。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To validate an imaging protocol for the management of solitary central cartilage tumours (CCTs) of the proximal humerus and around the knee.

MATERIALS AND METHODS: Over a 10-year period, 387 patients were identified with a CCT in the proximal humerus, distal femur, and proximal tibia, who were referred to a single unit either from primary/secondary care or tertiary care directly to Royal Orthopaedic Hospital, a specialist orthopaedic oncology service. The initial magnetic resonance imaging (MRI) images and any follow-up images were evaluated for length of tumour, presence/absence of endosteal scalloping, or aggressive/malignant features. The cases were categorised into one of seven types according to the Birmingham Atypical Cartilage Tumour Imaging Protocol (BACTIP). The outcome in the cases was assessed to ascertain if application of the protocol would have led to any delay in the diagnosis of malignant transformation to a chondrosarcoma.

RESULTS: The incidence of malignancy (chondrosarcoma) increased with ascending BACTIP. There was a 100% benign diagnosis (enchondroma) in types IA and IB, 96% in IIA, and 83% in IIB. Fifty-seven percent of type IIC and 97% type III were diagnosed as malignant. In only one case would the application of the protocol have led to a 5-month delay in the diagnosis of chondrosarcoma.

CONCLUSIONS: This retrospective study confirms the BACTIP as a useful tool for the general radiologist in the initial assessment of CCT in the proximal humerus and around the knee with the exception of the proximal fibula. In particular, determining which cases need prompt referral to a specialist orthopaedic oncology service for further assessment.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Davies AM, Patel A, James SL, et al. A retrospective validation of an imaging protocol for the management of solitary central cartilage tumours of the proximal humerus and around the knee. Clin Radiol. 2019. PMID: 31587800. doi:10.1016/j.crad.2019.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。